EcoDrugPlus

Lysyl Oxidase-Like 2a

Ensembl ID : ENSPFOG00000007034
Gene Symbol: LOXL2A
1 Cross references
209 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSPFOG00000007163
Gene Symbol: MIF
3 Cross references
229 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSPFOG00000006925
Gene Symbol: MST1R
2 Cross references
193 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSPFOG00000016463
Gene Symbol: LOC103137246
2 Cross references
188 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSPFOG00000014822
Gene Symbol: LOC103137773
3 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSPFOG00000009342
Gene Symbol: MMP14
3 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSPFOG00000016045
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSPFOG00000024073
Gene Symbol: MMP9
1 Cross references
201 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSPFOG00000001844
Gene Symbol: MMP9
1 Cross references
201 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSPFOG00000002170
Gene Symbol: MMP9
1 Cross references
206 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSPFOG00000012272
Gene Symbol: MMP9
1 Cross references
202 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSPFOG00000016510
Gene Symbol: LOC103138402
3 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).